Par Drugs and Chemicals Limited — Board Meeting, 22-10-2024: Outcome of Board Meeting

Par Drugs and Chemicals Limited's Board approved the unaudited standalone financial results for the quarter and half year ended September 30, 2024, reporting a profit of ₹859.58 lakhs. The Board also reviewed investor grievances, the corporate governance report, and approved advertisements for the financial results in newspapers. Additionally, the trading window will open 48 hours post-announcement. No significant other items were discussed during the meeting.